首页> 外文期刊>Clinical and Translational Allergy >How to manage anaphylaxis in primary care
【24h】

How to manage anaphylaxis in primary care

机译:如何在基层医疗中管理过敏反应

获取原文
           

摘要

Anaphylaxis is defined as a severe life-threatening generalized or systemic hypersensitivity reaction characterized by rapidly developing airway and/or circulation problems. It presents with very different combinations of symptoms and apparently mild signs and can progress to fatal anaphylactic shock unpredictably. The difficulty in recognizing anaphylaxis is due, in part, to the variability of diagnostic criteria, which in turn leads to a delay in administration of appropriate treatment, thus increasing the risk of death. The use of validated clinical criteria can facilitate the diagnosis of anaphylaxis. Intramuscular epinephrine (adrenaline) is the medication of choice for the emergency treatment of anaphylaxis. Administration of corticosteroids and H1-antihistamines should not delay the administration of epinephrine, and the management of a patient with anaphylaxis should not end with the acute episode. Long-term management of anaphylaxis should include avoidance of triggers, following confirmation by an allergology study. Etiologic factors suspected in the emergency department often differ from the real causes of anaphylaxis. Evaluation of patients with a history of anaphylaxis should also include an assessment of personal data, such as age and comorbidities, which may increase the risk of severe reactions. Special attention should also be paid to co-factors, as these may easily confound the cause of the anaphylaxis. Patients experiencing anaphylaxis should administer epinephrine as soon as possible. Education (including the use of Internet and social media), written personalized emergency action plans, and self-injectable epinephrine have proven useful for the treatment of further anaphylaxis episodes.
机译:过敏反应定义为严重威胁生命的全身或全身超敏反应,其特征是迅速发展的气道和/或循环问题。它表现出非常不同的症状组合和明显的轻度体征,并且可能无法预测地发展为致命的过敏性休克。认识到过敏反应的困难部分是由于诊断标准的可变性,这反过来又导致了给予适当治疗的延迟,从而增加了死亡风险。使用经过验证的临床标准可以促进过敏反应的诊断。肌内肾上腺素(肾上腺素)是紧急治疗过敏反应的首选药物。皮质类固醇和H1-抗组胺药的给药不应延迟肾上腺素的给药,过敏反应患者的治疗不应以急性发作为终点。经过敏学研究确认后,长期进行过敏反应处理应避免使用诱因。急诊科怀疑的病因通常与过敏反应的真正原因不同。对有过敏反应史的患者的评估还应包括对个人数据的评估,例如年龄和合并症,这可能会增加发生严重反应的风险。还应特别注意辅因子,因为它们很容易混淆过敏反应的原因。发生过敏反应的患者应尽快服用肾上腺素。教育(包括使用互联网和社交媒体),书面的个性化紧急行动计划以及可自我注射的肾上腺素已被证明可用于治疗进一步的过敏反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号